OTCMKTS:SAEYY Redcare Pharmacy (SAEYY) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free SAEYY Stock Alerts $15.10 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$15.10▼$15.1050-Day Range$14.21▼$15.9552-Week Range$8.61▼$16.00VolumeN/AAverage Volume629 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Redcare Pharmacy alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Redcare Pharmacy Stock (OTCMKTS:SAEYY)Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands.Read More SAEYY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SAEYY Stock News HeadlinesApril 18, 2024 | markets.businessinsider.comEQS-News: Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.April 15, 2024 | finance.yahoo.comDespite currently being unprofitable, Redcare Pharmacy (ETR:RDC) has delivered a 297% return to shareholders over 5 yearsApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 4, 2024 | marketwatch.comRedcare Pharmacy Posts Higher Sales as Active Customer Base ExpandsApril 4, 2024 | markets.businessinsider.comEQS-News: Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.March 12, 2024 | markets.businessinsider.comGalenica continues to grow in the 2023 financial yearMarch 7, 2024 | finance.yahoo.comAnalysts Have Made A Financial Statement On Redcare Pharmacy NV's (ETR:RDC) Annual ReportMarch 6, 2024 | msn.comKirtland base pharmacy works long hours to fill prescriptions after Change Healthcare cyber-attackApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 6, 2024 | finance.yahoo.comRedcare Pharmacy Full Year 2023 Earnings: EPS Beats ExpectationsMarch 5, 2024 | msn.comRedcare Pharmacy aims for higher 2024 sales after positive annual core earningsMarch 2, 2024 | msn.comCheney Pharmacy among pharmacies nationwide impacted by cyberattackFebruary 22, 2024 | msn.comCybersecurity ‘issue’ disrupting some pharmaciesFebruary 7, 2024 | finance.yahoo.comInstitutional investors control 44% of Redcare Pharmacy NV (ETR:RDC) and were rewarded last week after stock increased 11%January 10, 2024 | finance.yahoo.comAt €145, Is It Time To Put Redcare Pharmacy NV (ETR:RDC) On Your Watch List?January 10, 2024 | markets.businessinsider.comEQS-News: Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.December 25, 2023 | finance.yahoo.comRedcare Pharmacy NV (ETR:RDC) Shares Could Be 46% Below Their Intrinsic Value EstimateDecember 6, 2023 | yahoo.comFormer Brighton MSP to be razed for unique pharmacyNovember 28, 2023 | finance.yahoo.comAnalysts Expect Breakeven For Redcare Pharmacy NV (ETR:RDC) Before LongNovember 18, 2023 | msn.comAfter walk-outs, pharmacists detail harsh working conditions and store closuresNovember 11, 2023 | morningstar.comRedcare Pharmacy NV ADR SAEYYNovember 5, 2023 | morningstar.comRedcare Pharmacy NV RDCNovember 4, 2023 | morningstar.comNeighbourly Pharmacy Inc NBLYNovember 3, 2023 | msn.comHere’s what the former Young’s Pharmacy site could become in Bethlehem TownshipNovember 1, 2023 | news.yahoo.comPharmacy workers participate in walkouts across the nationOctober 31, 2023 | marketwatch.comRedcare Pharmacy Sales Rise Amid High Demand in E-Prescription BusinessOctober 30, 2023 | msn.comThousands of pharmacy workers threaten walkout during 3-day 'Pharmageddon'See More Headlines Receive SAEYY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Redcare Pharmacy and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolOTCMKTS:SAEYY CUSIPN/A CIKN/A Webshop-apotheke-europe.com Phone800-200-800-300FaxN/AEmployees1,725Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Olaf Heinrich (Age 54)CEO & Member of the Managing Board Comp: $544.28kMr. Stephan Weber (Age 45)Co-Founder, Chief Commercial Officer, Deputy CEO & Member of the Managing Board Comp: $273.79kMr. Marc Fischer (Age 49)Co-Founder, Chief Information Officer & Member of the Managing Board Comp: $273.79kMr. Jasper F. P. Eenhorst (Age 51)CFO & Member of Management Board Comp: $482.01kMs. Theresa Holler (Age 51)COO & Member of the Managing Board Comp: $279.73kMonica AmbrosiAssociate Director of Investor RelationsMr. Patrick SchneiderChief Sales OfficerMs. Beate KroschDirector of Human ResourcesMr. Nana LohmannsChief E-Health OfficerMr. Jens WolfgartenChief Product Officer - RetailMore ExecutivesKey CompetitorsAlibaba Health Information TechnologyOTC:ALBHFAllstar Health BrandsOTCMKTS:ALSTClicks GroupOTCMKTS:CLCGYDocMorrisOTCMKTS:ZRSEFFire & FlowerOTCMKTS:FFLWFView All Competitors SAEYY Stock Analysis - Frequently Asked Questions Should I buy or sell Redcare Pharmacy stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Redcare Pharmacy in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" SAEYY shares. View SAEYY analyst ratings or view top-rated stocks. How have SAEYY shares performed in 2024? Redcare Pharmacy's stock was trading at $15.53 at the beginning of the year. Since then, SAEYY stock has decreased by 2.8% and is now trading at $15.10. View the best growth stocks for 2024 here. How do I buy shares of Redcare Pharmacy? Shares of SAEYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SAEYY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupWill this $2 AI stock double overnight?Behind the MarketsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Redcare Pharmacy NV Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.